Mononuclear cell secretome protects from experimental autoimmune myocarditis

European Heart Journal

Volumn 36, Issue 11, 2015, Pages 676-685a

  Hoetzenecker, Konrad ^a,b   Zimmermann, Matthias ^a,b   Hoetzenecker, Wolfram ^c   Schweiger, Thomas ^a,b   Kollmann, Dagmar ^a   Mildner, Michael ^d   Hegedus, Balazs ^a   Mitterbauer, Andreas ^a,b   Hacker, Stefan ^a,b   Birner, Peter ^a   Gabriel, Christian ^e   Gyöngyösi, Mariann ^a   Blyszczuk, Przemyslaw ^f,g   Eriksson, Urs ^f,g   Ankersmit, Hendrik Jan ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b INSTITUTE FOR MICROELECTRONICS   (Austria)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d Universitatsklinik fur Dermatologie   (Austria)

^e Red Cross Transfusion Service for Upper Austria   (Austria)

^f UNIVERSITY OF ZURICH   (Switzerland)

^g Zurich Regional Health Center   (Switzerland)

Author keywords

Conditioned medium; Mononuclear cells; Myocarditis; Secretome

Indexed keywords

AUTOANTIBODY; CASPASE 8; CYTOKINE; FREUND ADJUVANT; MYOSIN HEAVY CHAIN ALPHA; PROTEOME; SECRETOME; UNCLASSIFIED DRUG; ANTIBODY; CASPASE INHIBITOR; CD40 LIGAND; FAS LIGAND; FASL PROTEIN, MOUSE; MYH6 PROTEIN, MOUSE; MYOSIN HEAVY CHAIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CELL FUNCTION; CELL PROLIFERATION; CELL VIABILITY ASSAY; CONGESTIVE CARDIOMYOPATHY; DENDRITIC CELL; EXPERIMENTAL AUTOIMMUNE MYOCARDITIS; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATORY DILATED CARDIOMYOPATHY; JURKAT CELL LINE; MONONUCLEAR CELL; MOUSE; MYOCARDITIS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SPLEEN CELL; T-CELL LYMPHOMA CELL LINE; ANIMAL; AUTOIMMUNE DISEASES; BAGG ALBINO MOUSE; CD8+ T LYMPHOCYTE; CELL CULTURE; CYTOLOGY; DISEASE MODEL; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; SPLEEN;

ANIMALS; ANTIBODIES; APOPTOSIS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CASPASE INHIBITORS; CD4-CD8 RATIO; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; FAS LIGAND PROTEIN; HUMANS; MICE, INBRED BALB C; MYOCARDITIS; MYOSIN HEAVY CHAINS; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; SPLEEN;

EID: 84925272673     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehs459     Document Type: Article

References (42)

1. Feldman AM, McNamara D. Myocarditis. N Engl J Med 2000;343:1388-1398.
2. Cooper LT Jr. Myocarditis. N Engl J Med 2009;360:1526-1538.
3. Maisch B, Hufnagel G, Schonian U, Hengstenberg C. The European Study of Epidemiology and Treatment of Cardiac Inflammatory Disease (ESETCID). Eur Heart J 1995;16(Suppl O):173-175.
4. Mason JW, O'Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, Moon TE. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med 1995;333:269-275.
5. Hia CP, Yip WC, Tai BC, Quek SC. Immunosuppressive therapy in acute myocarditis: an 18 year systematic review. Arch Dis Child 2004;89:580-584.
6. Frustaci A, Russo MA, Chimenti C. Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. Eur Heart J 2009;30:1995-2002.
7. Gnecchi M, He H, Liang OD, Melo LG, Morello F, Mu H, Noiseux N, Zhang L, Pratt RE, Ingwall JS, Dzau VJ. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 2005;11: 367-368.
8. Angoulvant D, Ivanes F, Ferrera R, Matthews PG, Nataf S, Ovize M. Mesenchymal stem cell conditioned media attenuates in vitro and ex vivo myocardial reperfusion injury. J Heart Lung Transplant 2011;30:95-102.
9. Horn AP, Frozza RL, Grudzinski PB, Gerhardt D, Hoppe JB, Bruno AN, Chagastelles P, Nardi NB, Lenz G, Salbego C. Conditioned medium from mesenchymal stem cells induces cell death in organotypic cultures of rat hippocampus and aggravates lesion in a model of oxygen and glucose deprivation. Neurosci Res 2009;63:35-41.
10. Kim SY, Cho HS, Yang SH, Shin JY, Kim JS, Lee ST, Chu K, Roh JK, Kim SU, Park CG. Soluble mediators from human neural stem cells play a critical role in suppression of T-cell activation and proliferation. J Neurosci Res 2009;87: 2264-2272.
11. Ankersmit HJ, Hoetzenecker K, Dietl W, Soleiman A, Horvat R, Wolfsberger M, Gerner C, Hacker S, Mildner M, Moser B, Lichtenauer M, Podesser BK. Irradiated cultured apoptotic peripheral blood mononuclear cells regenerate infarcted myocardium. Eur J Clin Invest 2009;39:445-456.
12. Lichtenauer M, Mildner M, Hoetzenecker K, Zimmermann M, Podesser BK, Sipos W, Berenyi E, Dworschak M, Tschachler E, Gyongyosi M, Ankersmit HJ. Secretome of apoptotic peripheral blood cells (APOSEC) confers cytoprotection to cardiomyocytes and inhibits tissue remodelling after acute myocardial infarction: a preclinical study. Basic Res Cardiol 2011;106:1283-1297.
13. Lichtenauer M, Mildner M, Baumgartner A, Hasun M, Werba G, Beer L, Altmann P, Roth G, Gyongyosi M, Podesser BK, Ankersmit HJ. Intravenous and intramyocardial injection of apoptotic white blood cell suspensions prevents ventricular remodelling by increasing elastin expression in cardiac scar tissue after myocardial infarction. Basic Res Cardiol 2011;106:645-655.
14. Hoetzenecker K, Assinger A, Lichtenauer M, Mildner M, Schweiger T, Starlinger P, Jakab A, Berenyi E, Pavo N, Zimmermann M, Gabriel C, Plass C, Gyongyosi M, Volf I, Ankersmit HJ. Secretome of apoptotic peripheral blood cells (APOSEC) attenuates microvascular obstruction in a porcine closed chest reperfused acute myocardial infarction model: role of platelet aggregation and vasodilation. Basic Res Cardiol 2012;107:292.
15. Pummerer CL, Luze K, Grassl G, Bachmaier K, Offner F, Burrell SK, Lenz DM, Zamborelli TJ, Penninger JM, Neu N. Identification of cardiac myosin peptides capable of inducing autoimmune myocarditis in BALB/c mice. J Clin Invest 1996; 97:2057-2062.
16. Valaperti A, Marty RR, Kania G, Germano D, Mauermann N, Dirnhofer S, Leimenstoll B, Blyszczuk P, Dong C, Mueller C, Hunziker L, Eriksson U. CD11b+ monocytes abrogate Th17 CD4+ T cell-mediated experimental autoimmune myocarditis. J Immunol 2008;180:2686-2695.
17. Smith SC, Allen PM. Myosin-induced acute myocarditis is a T cell-mediated disease. J Immunol 1991;147:2141-2147.
18. Yuan HT, Liao YH, Wang Z, Dong JH, Cao LS, Wang ZH, Wang JP, Fu ML. Prevention of myosin-induced autoimmune myocarditis in mice by anti-L3T4 monoclonal antibody. Can J Physiol Pharmacol 2003;81:84-88.
19. Inomata T, Watanabe T, Haga M, Hirahara H, Abo T, Okura Y, Hanawa H, Kodama M, Izumi T. Anti-CD2 monoclonal antibodies prevent the induction of experimental autoimmune myocarditis. Jpn Heart J 2000;41:507-517.
20. Wang QQ, Wang YL, Yuan HT, Liu FQ, Jin YP, Han B. Immune tolerance to cardiac myosin induced by anti-CD4 monoclonal antibody in autoimmune myocarditis rats. J Clin Immunol 2006;26:213-221.
21. Eriksson U, Ricci R, Hunziker L, Kurrer MO, Oudit GY, Watts TH, Sonderegger I, Bachmaier K, Kopf M, Penninger JM. Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat Med 2003;9:1484-1490.
22. Eriksson U, Kurrer MO, Schmitz N, Marsch SC, Fontana A, Eugster HP, Kopf M. Interleukin-6-deficient mice resist development of autoimmune myocarditis associated with impaired upregulation of complement C3. Circulation 2003;107: 320-325.
23. Eriksson U, Kurrer MO, SebaldW, Brombacher F, Kopf M. Dual role of the IL-12/ IFN-gamma axis in the development of autoimmune myocarditis: induction by IL-12 and protection by IFN-gamma. J Immunol 2001;167:5464-5469.
24. Parrillo JE, Cunnion RE, Epstein SE, Parker MM, Suffredini AF, Brenner M, Schaer GL, Palmeri ST, Cannon RO III, Alling D, Wittes J, Ferrans V, Rodriguez R, Fauci A. A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. N Engl J Med 1989;321:1061-1068.
25. Howlett JG, McKelvie RS, Arnold JM, Costigan J, Dorian P, Ducharme A, Estrella-Holder E, Ezekowitz JA, Giannetti N, Haddad H, Heckman GA, Herd AM, Isaac D, Jong P, Kouz S, Liu P, Mann E, Moe GW, Tsuyuki RT, Ross HJ, White M. Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials. Can J Cardiol 2009;25:85-105.
26. Guidelines for diagnosis and treatment of myocarditis (JCS 2009): digest version. Circ J 2011;75:734-743.
27. Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, Glanowska G, Wilczewski P, Niklewski T, Zembala M, Polonski L, Rozek MM, Wodniecki J. Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation 2001; 104:39-45.
28. Frustaci A, Chimenti C, Calabrese F, Pieroni M, Thiene G, Maseri A. Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation 2003;107:857-863.
29. Caforio AL, Tona F, Bottaro S, Vinci A, Dequal G, Daliento L, Thiene G, Iliceto S. Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy. Autoimmunity 2008;41:35-45.
30. Neu N, Rose NR, Beisel KW, Herskowitz A, Gurri-Glass G, Craig SW. Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol 1987; 139:3630-3636.
31. Kania G, Blyszczuk P, Eriksson U. Mechanisms of cardiac fibrosis in inflammatory heart disease. Trends Cardiovasc Med 2009;19:247-252.
32. Le Blanc K, Tammik L, Sundberg B, Haynesworth SE, Ringden O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 2003;57:11-20.
33. Rasmusson I, Ringden O, Sundberg B, Le Blanc K. Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms. Exp Cell Res 2005;305:33-41.
34. Fazel S, Cimini M, Chen L, Li S, Angoulvant D, Fedak P, Verma S, Weisel RD, Keating A, Li RK. Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J Clin Invest 2006;116: 1865-1877.
35. Di Santo S, Yang Z, Wyler von Ballmoos M, Voelzmann J, Diehm N, Baumgartner I, Kalka C. Novel cell-free strategy for therapeutic angiogenesis: in vitro generated conditioned medium can replace progenitor cell transplantation. PLoS One 2009;4:e5643.
36. Korf-Klingebiel M, Kempf T, Sauer T, Brinkmann E, Fischer P, Meyer GP, Ganser A, Drexler H, Wollert KC. Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction. Eur Heart J 2008;29:2851-2858.
37. Ankersmit HJ, Ullrich R, Moser B, Hoetzenecker K, Hacker S, German P, Krenn C, Horvat R, Grimm M,Wolner E, Zuckermann A. Recovery from giant cell myocarditis with ECMO support and utilisation of polyclonal antithymocyte globulin: a case report. Thorac Cardiovasc Surg 2006;54:278-280.
38. Cooper LT Jr, Hare JM, Tazelaar HD, Edwards WD, Starling RC, Deng MC, Menon S, Mullen GM, Jaski B, Bailey KR, Cunningham MW, Dec GW. Usefulness of immunosuppression for giant cell myocarditis. Am J Cardiol 2008;102: 1535-1539.
39. Kallwellis-Opara A, Dorner A, Poller WC, Noutsias M, Kuhl U, Schultheiss HP, Pauschinger M. Autoimmunological features in inflammatory cardiomyopathy. Clin Res Cardiol 2007;96:469-480.
40. Caforio AL, Grazzini M, Mann JM, Keeling PJ, Bottazzo GF, McKenna WJ, Schiaffino S. Identification of alpha-and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation 1992;85:1734-1742.
41. Yang Z, von Ballmoos MW, Faessler D, Voelzmann J, Ortmann J, Diehm N, Kalka-Moll W, Baumgartner I, Di Santo S, Kalka C. Paracrine factors secreted by endothelial progenitor cells prevent oxidative stress-induced apoptosis of mature endothelial cells. Atherosclerosis 2010;211:103-109.
42. Lai RC, Arslan F, Lee MM, Sze NS, Choo A, Chen TS, Salto-Tellez M, Timmers L, Lee CN, El Oakley RM, Pasterkamp G, de Kleijn DP, Lim SK. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res 2010;4: 214-222.